Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAIREA Regulatory News (AIEA)

Share Price Information for AIREA (AIEA)

Share Price is delayed by 15 minutes
Get Live Data
27.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (3.704%)
Market Cap: £10.94m
AIEA Live PriceLast checked at - London Stock Exchange

Intraday AIREA Share Chart

Director/PDMR Shareholding

5 Apr 2019 11:42

RNS Number : 3103V
Airea PLC
05 April 2019
 

AIREA PLC

("the Company")

 

Director/PDMR Shareholding

 

 

The Company announces that Neil Rylance, Chief Executive Officer of the Company, has today sold 2,510,630 ordinary 25p shares in the Company ('Ordinary Shares') at a price of 72 pence per share to the recently created Airea Employee Benefit Trust ('EBT').

 

As a result of this transaction Neil Rylance no longer has a beneficial interest in the issued share capital of the Company.

 

Martin Toogood, Non-Executive Chairman, said:

 

"The Company's employee benefit trust is now in a position where it can begin to make performance-based share awards to our employees. The awards, which will vest over a three to five year period, are key to employee retention and ensuring that appropriate incentives are in place to drive long-term value creation in a highly competitive market environment.

 

Our Chief Executive Officer, Neil Rylance, built up his personal shareholding in the Company a number of years ago and, as part of this sale to the EBT, intends to continue to lead the company in this next important phase of its development".

 

 

AIREA plc

Martin Toogood, Non-Executive Chairman 01924 266561

Paul Stevenson, Finance Director 01924 262561

 

N+1 Singer, Nominated Adviser and Broker

Peter Steel 0207 496 3000

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail. 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCAs") with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Neil Rylance

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

AIREA plc

b)

LEI

213800FNWL76NCLZU343

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 25 pence each ("Ordinary Shares")

 

Identification code

GB00BW9PJQ87

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

Price

Volume

72p

2,510,630 Ordinary Shares

d)

Aggregated information

- Aggregated volume

- Price

 

 

2,510,630 Ordinary Shares

72p

e)

Date of the transaction

5 April 2019

f)

Place of the transaction

Outside a trading venue

 

Name of authorised official of issuer responsible for making notification:

Paul Stevenson

Company Secretary to AIREA plc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBELFBKZFXBBD
Date   Source Headline
16th Jun 20269:49 amRNSDirector / PDMR Dealing
8th Jun 20265:10 pmRNSExercise of Options / PDMR notification
6th May 20263:06 pmRNSResult of AGM
6th May 20262:00 pmRNSAGM Statement
20th Apr 202612:23 pmRNSDirector/PDMR Dealing
26th Mar 20267:00 amRNSFinal Results for the year ended 31 December 2025
9th Mar 20267:00 amRNSNotice of Results
11th Feb 20268:52 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSPre-close Trading Update
1st Oct 20259:08 amRNSHolding(s) in Company
30th Sep 20254:12 pmRNSDivestment of Investment Property
30th Sep 20257:00 amRNSInterim Results
29th Jul 20257:00 amRNSPre-close Trading Update and Notice of Results
7th May 20253:06 pmRNSResult of AGM
7th May 202512:01 pmRNSDirector/PDMR Dealing
7th May 202512:00 pmRNSAGM Statement
28th Mar 20257:00 amRNSDirector/PDMR Dealings
27th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20257:00 amRNS-ROpening of Dubai Showroom
23rd Jan 202510:40 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSPre-close Trading Update
26th Sep 202411:43 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSInterim Results
6th Aug 20247:00 amRNSPre-close Trading Update and Notice of Results
28th Jun 20247:00 amRNSLong Term Incentive Plan Awards
8th May 20243:07 pmRNSResult of AGM
8th May 202412:00 pmRNSAGM Statement
26th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
11th Mar 20247:00 amRNSNotice of Results
24th Jan 20247:00 amRNSTrading update and £5.0m investment in facility
3rd Oct 20237:00 amRNSAppointment of Chief Financial Officer
28th Jul 202310:30 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSInterim Results
4th Jul 20233:00 pmRNSDirectorate Change
22nd Jun 20237:00 amRNSHolding(s) in Company
10th May 20232:56 pmRNSResult of AGM
10th May 202312:00 pmRNSAGM Statement
10th May 20237:00 amRNSAppointment of Independent Non-Executive Director
13th Apr 20233:42 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSFinal Results for the year ended 31 December 2022
16th Dec 20227:00 amRNSLong Term Incentive Plan Awards
7th Dec 20224:59 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSAppointment of Chief Executive
29th Jul 20221:54 pmRNSHolding(s) in Company
28th Jul 20227:00 amRNSInterim Report
24th May 20223:02 pmRNSRe Dividend
17th May 20224:01 pmRNSResult of AGM
12th Apr 20227:00 amRNSFinal Results for the year ended 31 December 2021
29th Mar 20224:40 pmRNSDeath of a Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.